Apixio Inc., the data science company for healthcare, today announced that it has continued to grow its volume of business, achieving 210 percent year-over-year growth in patients analyzed. Apixio’s cognitive computing platform analyzes data from more than 6 million patients and 500 million medical documents, resulting in 5 billion analytic events that together provide groundbreaking insights for healthcare. Over the past year, Apixio has continued to unveil new features for its HCC Profiler solution, elevating the accuracy and speed of medical chart review to unprecedented levels.